Dem Biopharma
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
730 Main St, Cambridge, Massachusetts, 0...Website
www.dembiopharma.comRevenue
<$5 MillionIndustry
About Dem Biopharma
DEM BioPharma specializes in developing first-in-class cancer therapeutics targeting novel pathways for solid tumors. The company is focused on advancing its product pipeline, including the notable DEM301, which was recently presented at the 2026 ASCO Gastrointestinal Cancers Symposium. Their intended clients include healthcare professionals and institutions involved in cancer treatment and research. With a commitment to innovation, DEM BioPharma aims to contribute significantly to the field of oncology.Explore more
Dem Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Dem Biopharma
Compare insights from companies similar to Dem Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dem Biopharma Tech Stack
A closer look at the technologies used by Dem Biopharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dem Biopharma
Sign Up For FreeTo access detailed company insights
DEM BioPharma specializes in developing first-in-class cancer therapeutics targeting novel pathways for solid tumors. The company is focused on advancing its product pipeline, including the notable DEM301, which was recently presented at the 2026 ASCO Gastrointestinal Cancers Symposium. Their intended clients include healthcare professionals and in... Read More
